As one of the specialised divisions in the Ecsponent private equity stable, Ecsponent Biotech invests in products and services that promote the adoption of personalised and regenerative medicine among South Africans to improve their quality of life.
Additionally, Ecsponent Biotech focuses on the advancement of children’s health, by providing access to affordable, life-saving technologies to everyone who wants to make responsible and informed choices for their children. Investments in several international and local brands combine the technical excellence of leading biotech organisations with Ecsponent’s local business expertise. These investments include Cryo-Save (Europe’s largest stem cell bank) and Salveo Swiss Biotechnology (Geneva-based leader in predictive medicine).
Create opportunities to improve the health and quality of life of all South Africans, through advanced predictive and regenerative medicine solutions.
To advance the health of children, we provide access to affordable, life-saving technologies to communities.
We create awareness and promote education about umbilical cord stem cell storage – its current and future medical applications – as well as a host of other potentially lifesaving and quality-of-life-improving products and services.